נאופרו 4 מ"ג / 24 שעות

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

ROTIGOTINE 4 MG / 24 HOUR

Disponible desde:

CTS LTD

Código ATC:

N04BC09

formulario farmacéutico:

PATCHES

Vía de administración:

TRANSDERMAL

Fabricado por:

UCB MANUFACTURING IRELAND LTD

Grupo terapéutico:

ROTIGOTINE

indicaciones terapéuticas:

Neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through the late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or "on-off" fluctuations).

Fecha de autorización:

2012-09-01